Ginkgo Bioworks Holdings, Inc. Given Consensus Recommendation of Reduce by Brokerages - MarketBeat
| BIOWKS Stock | SEK 1.46 0.02 1.35% |
About 61% of Bio Works' investor base is looking to short. The analysis of current outlook of investing in Bio Works Technologies AB suggests that many traders are alarmed regarding Bio Works' prospects. The current market sentiment, together with Bio Works' historical and current headlines, can help investors time the market. In addition, many technical investors use Bio Works Technologies stock news signals to limit their universe of possible portfolio assets.
Bio |
Ginkgo Bioworks Holdings, Inc. Given Consensus Recommendation of Reduce by Brokerages MarketBeat
Read at news.google.com
 |
Bio Works Fundamental Analysis
We analyze Bio Works' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio Works using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Works based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
Bio Works is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Bio Works Technologies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bio Works stock to make a market-neutral strategy. Peer analysis of Bio Works could also be used in its relative valuation, which is a method of valuing Bio Works by comparing valuation metrics with similar companies.
Peers
Bio Works Related Equities
| IVACC | Intervacc | 6.93 | ||||
| XBRANE | Xbrane Biopharma | 6.67 | ||||
| CRAD-B | C Rad | 2.34 | ||||
| CANTA | Cantargia | 1.15 | ||||
| GENO | Genovis AB | 2.14 |
Complementary Tools for Bio Stock analysis
When running Bio Works' price analysis, check to measure Bio Works' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Works is operating at the current time. Most of Bio Works' value examination focuses on studying past and present price action to predict the probability of Bio Works' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Works' price. Additionally, you may evaluate how the addition of Bio Works to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| CEOs Directory Screen CEOs from public companies around the world |